Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors

彭布罗利珠单抗 医学 内科学 肿瘤科 伴生诊断 免疫组织化学 置信区间 PD-L1 病理 癌症 免疫疗法
作者
Antonio Marchetti,Massimo Barberis,Renato Franco,Graziano De Luca,Marta Pace,Stefania Staibano,Marco Volante,Fiamma Buttitta,Elena Guerini‐Rocco,Luisella Righi,Tommaso D’Antuono,Giorgio Vittorio Scagliotti,Carmine Pinto,Gaetano De Rosa,Mauro Papotti
出处
期刊:Journal of Thoracic Oncology [Elsevier]
卷期号:12 (11): 1654-1663 被引量:80
标识
DOI:10.1016/j.jtho.2017.07.031
摘要

Among the several agents targeting the programmed cell death 1 (PD-1) pathway, pembrolizumab is currently the only one approved for the treatment of patients with NSCLC in association with a companion diagnostic assay, the anti-PD-L1 immunohistochemical (IHC) 22C3 PharmDx (Agilent Technologies, Santa Clara, CA) using the Dako Autostainer (Dako, Carpinteria, CA). However, the Dako platform is not present in each pathology department, and this technical limitation is a major problem for the diffusion of the PD-L1 IHC predictive test for pembrolizumab.The Italian Society of Anatomic Pathology and Cytopathology and the Italian Association of Medical Oncology in an independent, multicenter study compared the in vitro diagnostics PD-L1 IHC 22C3 pharmDx test (Agilent) on the Dako Autostainer and the in vitro diagnostics Ventana PD-L1 (SP263) test on the Ventana BenchMark platform (Ventana Medical Systems, Tucson, AZ). Using serial sections from tissue microarrays, 100 lung adenocarcinomas were locally stained and scored in four centers with the same antibody batches.A high analytical correlation (more than 90% at the lower 95% confidence interval [CI] value) between PD-L1 expression levels obtained with the 22C3 and SP263 assays was observed. At the proposed clinically relevant cutoffs (≥50% and ≥1%), the overall concordances between 22C3 and SP263 data were 0.99 (95% CI: 0.96-1) and 0.80 (95% CI: 0.68-0.91), respectively. The lower agreement between data obtained with the 22C3 and SP263 clones at the cutoff of 1% or higher was mainly related to the lower (about 80%) interrater agreement at this cutoff with each clone.These results indicate a high correlation between PD-L1 IHC expression data obtained with the Agilent PD-L1 IHC 22C3 pharmDx and the Ventana PD-L1 (SP263) tests in NSCLC and suggest that the two assays could be utilized interchangeably as an aid to select patients for first-line and second-line treatment with pembrolizumab and potentially with other anti-PD-1/PD-L1 checkpoint inhibitors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
倪小呆完成签到 ,获得积分10
18秒前
liuq完成签到,获得积分20
33秒前
mailgo完成签到,获得积分10
36秒前
金生六完成签到 ,获得积分10
38秒前
所所应助liuq采纳,获得10
39秒前
淡淡菠萝完成签到 ,获得积分10
46秒前
49秒前
踏实手套完成签到 ,获得积分10
49秒前
ashley325完成签到 ,获得积分10
52秒前
liuq发布了新的文献求助10
53秒前
但大图完成签到 ,获得积分10
59秒前
chen完成签到,获得积分10
1分钟前
小明完成签到,获得积分10
1分钟前
1分钟前
知行合一完成签到 ,获得积分10
1分钟前
崔宁宁完成签到 ,获得积分10
1分钟前
陈荣完成签到 ,获得积分10
1分钟前
gogogo完成签到,获得积分10
1分钟前
mgqqlwq发布了新的文献求助10
1分钟前
HS完成签到,获得积分10
1分钟前
yes完成签到 ,获得积分10
1分钟前
英姑应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
BLAZe完成签到 ,获得积分10
2分钟前
岑靖仇完成签到 ,获得积分10
2分钟前
自由的亿先完成签到 ,获得积分10
2分钟前
guantlv完成签到,获得积分10
2分钟前
cyril完成签到 ,获得积分10
2分钟前
lyly完成签到,获得积分10
2分钟前
回首不再是少年完成签到,获得积分10
2分钟前
Oneplusssss完成签到 ,获得积分10
2分钟前
willam完成签到 ,获得积分10
2分钟前
倩倩完成签到,获得积分10
3分钟前
zzn完成签到 ,获得积分10
3分钟前
科研狗完成签到 ,获得积分10
3分钟前
wangeil007完成签到,获得积分10
3分钟前
wqc2060完成签到,获得积分10
3分钟前
赵焱峥完成签到 ,获得积分10
3分钟前
fay1987完成签到,获得积分10
3分钟前
onlooker完成签到 ,获得积分10
4分钟前
高分求助中
Un calendrier babylonien des travaux, des signes et des mois: Séries iqqur îpuš 1036
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Python Programming for Linguistics and Digital Humanities: Applications for Text-Focused Fields 500
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2546110
求助须知:如何正确求助?哪些是违规求助? 2175672
关于积分的说明 5600244
捐赠科研通 1896399
什么是DOI,文献DOI怎么找? 946268
版权声明 565379
科研通“疑难数据库(出版商)”最低求助积分说明 503557